SCHEMBL9941280

SCHEMBL9941280

COc1ccccc1-c1cc(C(=O)NC(Cc2ccc(-c3ccccc3)cc2)C[C@@H](O)C(=O)O)on1

nearest known ligand 0.75

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MME P08473 20/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9930483 1.00 MME (0.75) MME
SCHEMBL9941277 1.00 MME (0.75) MME
SCHEMBL15463993 0.86 MME (0.72) MME
SCHEMBL15464036 0.86 MME (0.80) MME
SCHEMBL9929650 0.86 MME (1.00) MME
SCHEMBL9937750 0.86 MME (1.00) MME
SCHEMBL23089774 0.85 MME (1.00) MME
SCHEMBL9938807 0.85 MME (1.00) MME
SCHEMBL9937683 0.85 MME (0.75) MME
SCHEMBL9930080 0.85 MME (0.75) MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651896-A1 NEPRILYSIN INHIBITORS Theravance, Inc. (US) 2013-10-23 EP disclosed
WO-2012082853-A1 NEPRILYSIN INHIBITORS THERAVANCE, INC. (US) 2012-06-21 WO disclosed